Bryan Kobel
Chief Executive Officer bei TC BIOPHARM (HOLDINGS) PLC
Vermögen: 773 $ am 30.11.2023
Aktive Positionen von Bryan Kobel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Director/Board Member | 01.06.2021 | - |
Chief Executive Officer | 01.06.2021 | - | |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - | - |
TC BioPharm (North America), Inc. | Chief Executive Officer | 01.06.2021 | - |
Karriereverlauf von Bryan Kobel
Ehemalige bekannte Positionen von Bryan Kobel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.06.2018 | 01.10.2020 |
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Corporate Officer/Principal | 01.04.2017 | 01.06.2018 |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 01.03.2012 | 01.04.2017 |
HUTN, INC. | Corporate Officer/Principal | 01.10.2020 | - |
Ausbildung von Bryan Kobel
Franklin & Marshall College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 4 |
Operativ
Corporate Officer/Principal | 5 |
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Sektoral
Finance | 5 |
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
HUTN, INC. | Finance |
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Private Unternehmen | 5 |
---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Finance |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Finance |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
TC BioPharm (North America), Inc. |
- Börse
- Insiders
- Bryan Kobel
- Erfahrung